Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study

Diabetes Obesity and Metabolism(2025)10.1111/dom.70054Source: DataRank Database

Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study is a research paper published in Diabetes Obesity and Metabolism (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: hybridTopics (23)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Yiwen Lu ORCID,Bingyu Zhang ORCID,Ting Zhou ORCID,Dazheng Zhang ORCID,Jiajie Chen ORCID

Live enrichment

PubMed:40874398 PMC:PMC12515787

Clinical Center

Grant: R01AG073435

Clinical Center

Grant: R01DK128237

Clinical Center

Grant: R01LM013519

Clinical Center

Grant: R21AI167418

Clinical Center

Grant: R21EY034179

Clinical Center

Grant: R56AG074604

Clinical Center

Grant: RF1AG077820

Clinical Center

Grant: U01TR003709

Clinical Center

Grant: U24MH136069

hybridLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.70054

publisherhttps://dom-pubs.pericles-prod.literatumonline.com/doi/pdf/10.1111/dom.70054

publisherhttps://dom-pubs.pericles-prod.literatumonline.com/doi/full-xml/10.1111/dom.70054

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12515787

Europe_PMChttps://europepmc.org/articles/PMC12515787

MeSH Terms

KidneyHumansKidney DiseasesCardiovascular DiseasesDiabetes Mellitus, Type 2ObesityAnti-Obesity AgentsHypoglycemic AgentsTreatment OutcomeAdultAgedMiddle AgedFemaleMaleGlucagon-Like Peptide 1Glucagon-Like PeptidesLiraglutideGlucagon-Like Peptide-1 Receptor AgonistsSemaglutide

Keywords

Major Adverse Cardiovascular EventsGlp‐1 Receptor AgonistsMajor Adverse Kidney EventsAnti‐Obesity Medication